References
- Hagenmeyer EG, Haussler B, Hempel E, et al. Resource use and treatment costs after kidney transplantation: Impact of demographic factors, comorbidities, and complications. Transplantation. 2004;77:1545–1549.
- Hsiao SH, Huang WC, Sy CL, Lin SK, Lee TY, Liu CP. Doppler tissue imaging and color M-mode flow propagation velocity: Are they really preload independent? J Am Soc Echocardiogr. 2005;18:1277–1284.
- Arjona Barrionuevo JD, Gonzáles Vargas-Machuca MF, Gómez Pulido F, Gil Sacaluga L, Gentil Govantes MA, Martínez-Martínez A. Transthoracic echocardiographic findings in patients with chronic kidney disease awaiting kidney transplantation. Transplant Proc. 2010;42:3123–3125.
- Israni AK, Snyder JJ, Skeans MA, Peng Y, et al. Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) study. Am J Transplant. 2010;10:338–353.
- Qiu J, Cai J, Terasaki PL. Death with a functioning graft in kidney transplant recipients. Clin Transpl. 2004;18:379–386.
- Weiner DE, Carpenter MA, Levey AS, et al. Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: The FAVORIT trial. Am J Transplant. 2012;12:2437–2445.
- Svensson M, Jardine A, Fellstrom B, Holdaas H. Prevention of cardiovascular disease after renal transplantation. Curr Opin Organ Transplant. 2012;17:393–400.
- Soveri I, Holme I, Holdaas H, Budde K, Jardine AG, Fellström B. A cardiovascular risk calculator for renal transplant recipients. Transplantation. 2012;94:57–62.
- Silver SA, Huang M, Nash MM, Prasad GV. Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients. Transplantation. 2011;92:183–189.
- Pita-Fernandez S, Pertega-Diaz S, Valdes-Canedo F, et al. Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: Study protocol. BMC Cardiovasc Disord. 2011;11:2.
- Kennedy JW, Kaiser GC, Fisher LD, et al. Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS). Circulation. 1981;63:793–802.
- Dahl JS, Eleid MF, Michelena HI, et al. Effect of left ventricular ejection fraction on postoperative outcome in patients with severe aortic stenosis undergoing aortic valve replacement. Circ Cardiovasc Imaging. 2015;8:2917–2926.
- Lang RM, Bierig M, Devereux RB, et al. Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463.
- Pilmore HL, Skeans MA, Snyder JJ, Israni AK, Kasiske BL. Cardiovascular disease medications after renal transplantation: Results from the patient outcomes in renal transplantation study. Transplantation. 2011;91:542–551.
- Pilmore H, Dent H, Chang S, McDonald SP, Chadban SJ. Reduction in cardiovascular death after kidney transplantation. Transplantation. 2010;89:851–857.
- Lentine KL, Villines TC, Xiao H, et al. Cardioprotective medication use after acute myocardial infarction in kidney transplant recipients. Transplantation. 2011;91:1120–1126.
- Cross NB, Webster AC, Masson P, O’Connell PJ, Craig JC. Antihypertensives for kidney transplant recipients: Systematic review and meta-analysis of randomized controlled trials. Transplantation. 2009;88:7–18.